Next, we aimed to establish UNC and EPZ drug response gene signatures from NB cell lines as surrogate measures of EHMT and EZH2 activity for the analysis of transcriptomes from NB patient samples (figure 6A). The gene discussed is EZH2; the disease is neuroblastoma.